NeOnc reports early improvement in 1 pediatric patient
NeOnc Technologies Holdings (NASDAQ:NTHI) reported early clinical improvements in one three-year-old brain tumor patient receiving investigational intranasal NEO100 through its Compassionate Care program in Abu Dhabi.










